Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EBIT Margin

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EBIT Margin History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   EBIT Margin(%) 18.8625.2126.4923.9518.45

What is the latest EBIT Margin ratio of MANKIND PHARMA ?

The latest EBIT Margin ratio of MANKIND PHARMA is 18.86 based on Mar2023 Consolidated results.
Year EBIT Margin
Mar202318.86
Mar202225.21
Mar202126.49
Mar202023.95
Mar201918.45

How is EBIT Margin of MANKIND PHARMA Trending?

Years EBIT Margin % Change
Mar2023 18.86
-25.19
Mar2022 25.21
-4.83
Mar2021 26.49
10.61
Mar2020 23.95
29.81
Mar2019 18.45 -

Other Financial Ratios of MANKIND PHARMA


Compare EBIT Margin ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹83,865.6 Cr -6.1% -11.9% 54.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,470.0 Cr -0.9% 0.9% 62.6% Stock Analytics
CIPLA ₹112,990.0 Cr 3.5% 4.2% 51.8% Stock Analytics
ZYDUS LIFESCIENCES ₹105,846.0 Cr 12.2% 18% 103.8% Stock Analytics
DIVIS LABORATORIES ₹103,849.0 Cr 0.8% 5.6% 19.3% Stock Analytics
DR REDDYS LABORATORIES ₹96,742.1 Cr -1% -2.4% 28.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-6.1%

-11.9%

54.1%

SENSEX

1.7%

0.7%

19.2%


You may also like the below Video Courses